Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP)
Architecture and Impact
PMBJP was launched by the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, to provide quality generic medicines at affordable prices through dedicated outlets called Pradhan Mantri Bhartiya Jan Aushadhi Kendras (PMBJAKs). The scheme builds on an earlier 2008 initiative and was significantly revamped and rebranded as PMBJP in 2015. Generic medicines are chemically identical to their branded equivalents — same active ingredient, same dosage, same quality — but sold without brand premiums. PMBI (the implementing bureau) procures medicines from government-approved manufacturers (including CPSEs and private manufacturers with Good Manufacturing Practice certification), ensuring quality parity.
- PMBJP medicines are priced 50-80% below branded equivalents, generating enormous household savings for poor and middle-class patients.
- The product basket covers over 2,000 medicines and 300 surgical devices — covering most common disease categories.
- Over 18,000 JAKs are operational across all states and UTs, including in tribal, hilly, and remote areas.
- Target: 25,000 JAKs by March 2027, ensuring one Kendra per 10,000 population in smaller towns and rural areas.
- The scheme has contributed to cumulative estimated savings of over ₹30,000 crore for consumers (as of 2024 data).
● Tracked since March 07, 2026 · last seen June 11, 2026 · updates as the daily brief publishes